SUN PHARMACEUTICAL INDUSTRIES INC recalls Liothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.
Recalled November 8, 2023 · FDA recall D-0083-2024 · SUN PHARMACEUTICAL INDUSTRIES
Hazard
Failed Impurities/Degradation Specifications. · FDA Class II
Units
7392 Bottles
Sold at
Nationwide within the United States
Description
Failed Impurities/Degradation Specifications.
Product
Liothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-589-88
Manufacturer(s)
SUN PHARMACEUTICAL INDUSTRIES INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →